Ulrike Scheffler | Senior Director Business Development
Icosagen

Ulrike Scheffler is the Senior Director of Business Development at Icosagen CRDMO, specializing in advancing complex recombinant proteins from discovery to GMP readiness. With 16+ years of experience, Ulrike combines a strong technical background from her time as a scientist at Roche Glycart with extensive expertise in business development.

At Icosagen, she bridges R&D and CMC, leveraging her knowledge in VLP-mAb discovery and developability assessments to address development challenges. Skilled in CHO cell line development using the IcoCell® platform, DoE-driven process development, and strategic scale-up, Ulrike helps clients navigate the complexities of biologics development, ensuring clinic-ready manufacturing.
Her unique combination of technical expertise and business acumen ensures the success of end-to-end CRDMO programs, delivering scalable solutions for biologics development.